XNCR: Xencor, Inc. Stock

by  •  • Comments Off on XNCR: Xencor, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,158.23
Enterprise Value ($M) 628.03
Book Value ($M) 669.13
Book Value / Share 10.95
Price / Book 1.73
NCAV ($M) 339.60
NCAV / Share 5.56
Price / NCAV 3.41

Profitability (mra)
Return on Invested Capital (ROIC) -0.17
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.18

Liquidity (mrq)
Quick Ratio 7.36
Current Ratio 7.36

Balance Sheet (mrq) ($M)
Current Assets 623.16
Assets 952.69
Liabilities 283.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 168.34
Operating Income -138.64
Net Income -126.09
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 85.11
Cash from Investing -111.06
Cash from Financing 26.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-16 13G/A T. Rowe Price Investment Management, Inc. 2.20 0.00
02-14 13G/A Price T Rowe Associates Inc /md/ 5.70 8.42
02-14 13G/A EcoR1 Capital, LLC 8.70 0.00
02-13 13G/A Vanguard Group Inc 11.12 1.73
02-12 13G/A Primecap Management Co/ca/ 14.62 43.18
02-09 13G/A Fmr Llc 4.21 -33.00
01-25 13G/A State Street Corp 5.47 5.41
01-19 13G/A BlackRock Inc. 18.60 6.34

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 o TRANSITION REPORT PURSUANT
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 82,742 684,323 12.09
2024-04-18 66,166 308,925 21.42
2024-04-17 58,020 455,908 12.73
2024-04-16 63,005 499,280 12.62
2024-04-15 67,670 386,573 17.51

(click for more detail)

Similar Companies
VRCA – Verrica Pharmaceuticals Inc. WVE – Wave Life Sciences Ltd.
XENE – Xenon Pharmaceuticals Inc. XOMA – XOMA Corporation


Financial data and stock pages provided by
Fintel.io